Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

COMBIVENT UNIT DOSE VIAL FOR INHALATION - HSA Drug Approval Details

Approvals/HSA/COMBIVENT UNIT DOSE VIAL FOR INHALATION

Approved

STANDARD

COMBIVENT UNIT DOSE VIAL FOR INHALATION

Unknown🇸🇬 Health Sciences Authority

Approval Date: Jan 13, 2026
Approval ID: c315779bab63cab3
Company: Unknown
Type: Standard

Approval Details

Approval Id: c315779bab63cab3
Drug Name: COMBIVENT UNIT DOSE VIAL FOR INHALATION

Active Ingredients

IPRATROPIUM BROMIDE MONOHYDRATE 0.52MG/2.5ML EQV. TO IPRATROPIUM BROMIDE ANHYDROUS

0.5 mg/2.5 ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 13, 2026

Approval ID

c315779bab63cab3

Type

Standard

Back to HSA Approvals